D165-0342 Screening compound: 7-bromo-4-(4-butoxyphenyl)-2-(pyridin-4-yl)-1H-1,3,5-benzotriazepine

D165-0342 Screening compound: 7-bromo-4-(4-butoxyphenyl)-2-(pyridin-4-yl)-1H-1,3,5-benzotriazepine
D165-0342 Screening compound: 7-bromo-4-(4-butoxyphenyl)-2-(pyridin-4-yl)-1H-1,3,5-benzotriazepine alternative view

Chemical Structure Depiction of ChemDiv screening compound D165-0342
7-bromo-4-(4-butoxyphenyl)-2-(pyridin-4-yl)-1H-1,3,5-benzotriazepine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D165-0342

Molecular Formula

C23H21BrN4O (C23 H21 BrN4 O)

Compound Name

7-bromo-4-(4-butoxyphenyl)-2-(pyridin-4-yl)-1H-1,3,5-benzotriazepine

IUPAC name

7-bromo-4-(4-butoxyphenyl)-2-(pyridin-4-yl)-1H-135-benzotriazepine

SMILES

CCCCOc(cc1)ccc1C1=Nc(cc(cc2)Br)c2NC(c2ccncc2)=N1

InChI

InChI=1S/C23H21BrN4O/c1-2-3-14-29-19-7-4-16(5-8-19)22-27-21-15-18(24)6-9-20(21)26-23(28-22)17-10-12-25-13-11-17/h4-13,15H,2-3,14H2,1H3,(H,26,27,28)

InChI Key

HCMXMPDSEDOORC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14813409

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.35

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.573

Distribution Coefficient, logD

5.571

Water Solubility, LogSw

-5.28

Polar Surface Area

48.321

Acid Dissociation Constant (pKa)

9.96

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.40

D165-0342 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

KRAS-Targeted Library (16000 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with D165-0342 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D165-0342?
Check Price and Availability of D165-0342, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D165-0342 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D165-0342
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D165-0342
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D165-0342 available by request